CANGRELOR USE PATTERNS AND TRANSITION TO ORAL P2Y12 INHIBITORS--INITIAL FINDINGS FROM THE CAMEO REGISTRY

  • The Duke Clinical Research Institute Principal Investigator and Co-Investigator of the CAMEO registry will be hosting a podcast in which they discuss preliminary findings from the registry. In clinical trials, cangrelor has been shown to reduce percutaneous coronary intervention–related ischemic complications without increasing major bleeding. This podcast will focus on real-world cangrelor use and transition to oral P2Y12 inhibitors in routine clinical practice using initial findings from the CAMEO Registry.

Target Audience

  • Fellows
  • Medical Students
  • Nurses
  • Nurse Practitioners
  • Physicians
  • Physician Assistants
  • Pharmacy Technicians
  • Pharmacists
  • Residents

Learning Objectives

  • The learning objectives are optimization of cangrelor dosing, infusion duration, and transition of care from the catheterization laboratory to the ward setting.
Course summary
Available credit: 
  • 0.50 ACPE - Pharmacist
  • 0.50 ACPE - Pharmacy Technician
  • 0.50 AMA PRA Category 1 Credit(s)™
  • 0.50 ANCC
  • 0.00 Attendance
  • 0.10 IACET CEU
  • 0.50 JA Credit - AH
    • 0.50 Approved for AMA PRA Category 1 Credit(s)™
Registration Opens: 
03/24/2023
Registration Expires: 
03/24/2024
Rating: 
0
Durham, NC 27705
United States
  • Jennifer Rymer

            Speaker

  • Jeffrey Washam

           Speaker

 

  • ACPE - Pharmacy Technician
  • ACPE - Pharmacist
  • AMA PRA Category 1 Credit(s)
  • ANCC
  • Attendance

Available Credit

  • 0.50 ACPE - Pharmacist
  • 0.50 ACPE - Pharmacy Technician
  • 0.50 AMA PRA Category 1 Credit(s)™
  • 0.50 ANCC
  • 0.00 Attendance
  • 0.10 IACET CEU
  • 0.50 JA Credit - AH
    • 0.50 Approved for AMA PRA Category 1 Credit(s)™
Please login or register to take this course.